Blast Phase Terminated Phase 2 Trials for Omacetaxine mepesuccinate (DB04865)

IndicationStatusPhase
DBCOND0031148 (Blast Phase)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00114959Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)Treatment